2017 Round Table
Access to innovation & medical research
The involvement of the different sectors interested in health research: health, social security, higher education, clinical experts
Designation of a strategy and research priorities (who has access to innovation, rationalization issue)
The creation of a culture and training / teaching on clinical studies, especially for observational studies in particular
Train for the acquisition of scientific, technological, procedural skills between CROs / Multinationals / Ministry of Health; Coordinators / investigators / pharmacists
Audience
- Director Geenral of Pharmacy, Pr. Fraihat
- Director General of Social Security, Djaouad Bourkaib & Dr. Mohamed Lamine Ghanem
- President of the Algerian Association for Biotechnology & Clinical Research, Salah Sahraoui
- Advisors from the MOH: Said Mekkaoui, Badra Benkedadra
- Senior management of companies & healthcare sector representative : Novo Nordisk, AstraZeneca, Clinica Group, Merck, ANPP, Deloitte, Sevier
- KOL
Attending Experts
Hamdi Akan
The Department of Hematology, Ankara University School of Medicine, Ankara, Turkey
Thais PONTES
General manager, CIDP Brazil
Dr. Emad Shafout,
CTL, INC Research® Jordanie
Stefano Marini
President, EUCROF, the European CRO Federation.
Dr. Lamine Mahi
for AFCROS
